product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Cas9 (7A9-3A3) Mouse mAb
catalog :
14697
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
7A9-3A3
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 9
Reference
Chen C, Yu W, Tober J, Gao P, He B, Lee K, et al. Spatial Genome Re-organization between Fetal and Adult Hematopoietic Stem Cells. Cell Rep. 2019;29:4200-4211.e7 pubmed publisher
Sullivan N, Dampier W, Chung C, Allen A, Atkins A, Pirrone V, et al. Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. Sci Rep. 2019;9:17088 pubmed publisher
Ferreira da Silva J, Salic S, Wiedner M, Datlinger P, Essletzbichler P, Hanzl A, et al. Genome-scale CRISPR screens are efficient in non-homologous end-joining deficient cells. Sci Rep. 2019;9:15751 pubmed publisher
Zuo Z, Zolekar A, Babu K, Lin V, Hayatshahi H, Rajan R, et al. Structural and functional insights into the bona fide catalytic state of Streptococcus pyogenes Cas9 HNH nuclease domain. elife. 2019;8: pubmed publisher
Mangeot P, Risson V, Fusil F, Marnef A, Laurent E, Blin J, et al. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun. 2019;10:45 pubmed publisher
Lee M, Lin J, Lin Y, Chang J, Ke H, Fan W, et al. Genome-wide prediction of CRISPR/Cas9 targets in Kluyveromyces marxianus and its application to obtain a stable haploid strain. Sci Rep. 2018;8:7305 pubmed publisher
Gergen J, Coulon F, Creneguy A, Elain Duret N, Gutierrez A, Pinkenburg O, et al. Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene. PLoS ONE. 2018;13:e0192602 pubmed publisher
Schimmel J, Kool H, van Schendel R, Tijsterman M. Mutational signatures of non-homologous and polymerase theta-mediated end-joining in embryonic stem cells. EMBO J. 2017;36:3634-3649 pubmed publisher
Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.